|
IL180161D0
|
|
Use of cb2 receptors agonists for the treatment of huntington's disease
|
|
EP1758566A2
|
|
Use of cb2 receptors agonists for the treatment of huntington"s disease
|
|
IL120184D0
|
|
Pharmaceutical compositions comprising permanently charged derivatives of steroid agonists or antagonists for preventing angiogenesis
|
|
IL119176D0
|
|
Soluble coprecipitates for enhanced oral bioavailability of lipophilic substances
|
|
IL117773D0
|
|
Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
|
|
IL102984D0
|
|
Ophthalmic compositions comprising pilocarpine
|
|
IL101387D0
|
|
Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
|
|
IL101007D0
|
|
Dry stable compositions prepared by lyophilization
|
